Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ACADEMIA
ACADEMIA
- In Renewed Attempt, Tokushima Univ. Starts IIT for Eisai-Dropped ALS Drug Candidate
November 9, 2017
- Japan’s 1st Constipation Treatment Guidelines Recommend Drugs Acting on Epithelial Function Including Amitiza
October 25, 2017
- Nephrology Society to Build Database, Biobank to Support Drug Discovery; Some 20 Companies Interested in Collaboration
October 13, 2017
- AMED Study Group to Investigate Drugs to Recommend in Elderly Depression Patients; Findings to Be Reflected in New Guidelines
September 7, 2017
- Over 150 Clinical Trials of Epigenetic Drugs, Some with Novel Mechanisms of Action, Underway Worldwide
August 31, 2017
- Opdivo-Induced Myasthenia Gravis Tends to Become Severe: Keio Researchers
August 21, 2017
- Japan Gastric Cancer Association to Wait for Opdivo Nod before Guidelines Update, Keytruda Won’t Make It This Time
August 16, 2017
- NCCHD to Launch Panel to Study Real-World Drug Use in Children, Findings Might Be Used for Label Revisions
August 8, 2017
- Kyoto Univ. to Commence Trial of Drug Candidate Discovered in iPS Cells Research for Rare Bone Disease
August 3, 2017
- Drug Vial Optimization Reduces Drug Expenditure, with Biggest Savings for Opdivo: Study
August 2, 2017
- Hypertension Treatment Guidelines for Elderly Finalized with Recommendations on Dosage Reduction, Discontinuation
July 21, 2017
- JSHR to Conduct 20-Year Follow-Up Study in Up to 100,000 Patients to Determine Efficacy of H. Pylori Eradication Therapy at Preventing Stomach Cancer
July 14, 2017
- New Treatment GL for Advanced HCC to Be Issued in October, Will Recommend Nexavar for 1st-Line Treatment
July 11, 2017
- Cure Can Be Expected Now for Colon Cancer Due to Advances in Pharmacotherapy: Oncologist
July 5, 2017
- Long-Term Safety of PCSK9 Inhibitors Remains to Be Determined: New Atherosclerosis Prevention Guidelines
July 4, 2017
- Japanese Society of Hypertension to Verify Results of SPRINT Study
June 14, 2017
- AbbVie’s Novel Hep C Treatment Achieves 100% SVR in Genotype 1 Hepatitis C Patients with Compensated Cirrhosis
June 13, 2017
- DPP-4 Inhibitor Prevents Deterioration in Cardiac Diastolic Function in Diabetes Patients: Research Sub-Analysis
May 26, 2017
- Will Formularies Spread in Japan? Some Don’t Think So, but MOF Push Might Give Impetus
May 23, 2017
- “Authorized Biosimilars” Could Be Priced at 50% of Originators: Prof.
May 23, 2017
ページ
Japan’s health and finance ministers agreed late last year to go ahead with an “off-year” drug price revision in FY2027,…
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…